$AMPH
Amphastar Pharmaceuticals, Inc.

2024 Q2 Form 10-Q Financial Statement

#000129718424000037 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $182.4M $171.8M
YoY Change 25.17% 22.72%
Cost Of Revenue $87.23M $81.74M
YoY Change 19.53% 23.5%
Gross Profit $95.17M $90.10M
YoY Change 30.83% 22.02%
Gross Profit Margin 52.18% 52.43%
Selling, General & Admin $22.30M $25.05M
YoY Change 17.36% 21.63%
% of Gross Profit 23.43% 27.8%
Research & Development $17.65M $17.04M
YoY Change 4.8% -13.99%
% of Gross Profit 18.55% 18.92%
Depreciation & Amortization $9.676M $9.662M
YoY Change 215.9% 184.26%
% of Gross Profit 10.17% 10.72%
Operating Expenses $39.95M $42.09M
YoY Change 11.46% 4.17%
Operating Profit $55.22M $48.01M
YoY Change 49.66% 43.6%
Interest Expense -$5.272M $8.611M
YoY Change -246.36% 2063.57%
% of Operating Profit -9.55% 17.94%
Other Income/Expense, Net -$4.974M -$134.0K
YoY Change 21.67% -198.53%
Pretax Income $50.24M $47.88M
YoY Change 53.14% 42.62%
Income Tax $12.29M $4.126M
% Of Pretax Income 24.47% 8.62%
Net Earnings $37.95M $43.18M
YoY Change 45.26% 65.86%
Net Earnings / Revenue 20.81% 25.13%
Basic Earnings Per Share $0.77 $0.90
Diluted Earnings Per Share $0.73 $0.81
COMMON SHARES
Basic Shares Outstanding 48.90M 48.10M
Diluted Shares Outstanding 52.05M 53.01M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $217.8M $289.6M
YoY Change 33.49% 50.11%
Cash & Equivalents $189.6M $201.1M
Short-Term Investments $28.16M $88.41M
Other Short-Term Assets $10.38M $11.13M
YoY Change -3.5% 14.02%
Inventory $122.4M $115.5M
Prepaid Expenses
Receivables $131.4M $138.1M
Other Receivables $667.0K $784.0K
Total Short-Term Assets $482.6M $555.1M
YoY Change 25.51% 36.16%
LONG-TERM ASSETS
Property, Plant & Equipment $288.0M $288.5M
YoY Change -5.73% 18.5%
Goodwill $3.129M $3.152M
YoY Change -1.14% -0.72%
Intangibles
YoY Change
Long-Term Investments $9.944M $15.16M
YoY Change 580.16% 762.51%
Other Assets $24.26M $23.37M
YoY Change -60.32% 26.07%
Total Long-Term Assets $1.009B $1.019B
YoY Change 1.53% 178.49%
TOTAL ASSETS
Total Short-Term Assets $482.6M $555.1M
Total Long-Term Assets $1.009B $1.019B
Total Assets $1.492B $1.574B
YoY Change 8.22% 103.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.78M $36.53M
YoY Change -85.39% 66.22%
Accrued Expenses $99.44M $80.16M
YoY Change 3073.86% 19.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $249.0K $428.0K
YoY Change -98.07% -80.26%
Total Short-Term Liabilities $137.0M $255.2M
YoY Change -45.49% 141.56%
LONG-TERM LIABILITIES
Long-Term Debt $586.9M $594.0M
YoY Change 20.19% 715.14%
Other Long-Term Liabilities $18.80M $17.98M
YoY Change -61.83% 18.49%
Total Long-Term Liabilities $18.80M $17.98M
YoY Change -96.5% 18.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $137.0M $255.2M
Total Long-Term Liabilities $18.80M $17.98M
Total Liabilities $778.2M $902.0M
YoY Change -1.38% 300.73%
SHAREHOLDERS EQUITY
Retained Earnings $490.4M $452.4M
YoY Change 51.41% 51.95%
Common Stock $6.000K $6.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $255.8M $247.4M
YoY Change 29.56% 25.24%
Treasury Stock Shares
Shareholders Equity $713.3M $672.4M
YoY Change
Total Liabilities & Shareholders Equity $1.492B $1.574B
YoY Change 8.22% 103.49%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $37.95M $43.18M
YoY Change 45.26% 65.86%
Depreciation, Depletion And Amortization $9.676M $9.662M
YoY Change 215.9% 184.26%
Cash From Operating Activities $69.11M $55.29M
YoY Change 25.83% 36.92%
INVESTING ACTIVITIES
Capital Expenditures $6.044M $8.793M
YoY Change -33.24% -7.22%
Acquisitions
YoY Change
Other Investing Activities -$63.86M $24.03M
YoY Change -87.22% 664.31%
Cash From Investing Activities -$69.90M $15.24M
YoY Change -86.26% -340.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $98.00K
YoY Change -89.88%
Cash From Financing Activities -10.72M -13.58M
YoY Change -102.5% 0.23%
NET CHANGE
Cash From Operating Activities 69.11M 55.29M
Cash From Investing Activities -69.90M 15.24M
Cash From Financing Activities -10.72M -13.58M
Net Change In Cash -11.51M 56.85M
YoY Change -54.95% 177.1%
FREE CASH FLOW
Cash From Operating Activities $69.11M $55.29M
Capital Expenditures $6.044M $8.793M
Free Cash Flow $63.07M $46.50M
YoY Change 37.49% 50.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Pension Expense
PensionExpense
0
CY2024Q1 us-gaap Pension Expense
PensionExpense
0
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Amphastar Pharmaceuticals, Inc.
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001297184
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-36509
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0702205
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
11570 6th Street
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Rancho Cucamonga
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91730
CY2024Q1 dei City Area Code
CityAreaCode
909
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
980-9484
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
AMPH
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48901965
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201148000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
144296000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
235000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
235000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
88407000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
112510000
CY2024Q1 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
CY2023Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
138114000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
114943000
CY2024Q1 us-gaap Inventory Net
InventoryNet
115494000
CY2023Q4 us-gaap Inventory Net
InventoryNet
105833000
CY2024Q1 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
784000
CY2023Q4 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
526000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8696000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9057000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
555078000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
489600000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
288523000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282746000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
516000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
564000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31352000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32333000
CY2023Q4 amph Investment In Unconsolidated Affiliate
InvestmentInUnconsolidatedAffiliate
527000
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
607064000
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
613295000
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
15163000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
14685000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23369000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25910000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
53252000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
53252000
CY2024Q1 us-gaap Assets
Assets
1574317000
CY2023Q4 us-gaap Assets
Assets
1512912000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
116697000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
93366000
CY2024Q1 amph Accrued Payments For Asset Acquisitions
AccruedPaymentsForAssetAcquisitions
128245000
CY2023Q4 amph Accrued Payments For Asset Acquisitions
AccruedPaymentsForAssetAcquisitions
126090000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5857000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1609000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
428000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
436000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3942000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3906000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
255169000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
225407000
CY2024Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
6066000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
6066000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
594006000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
589579000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28739000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29721000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17981000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22718000
CY2024Q1 us-gaap Liabilities
Liabilities
901961000
CY2023Q4 us-gaap Liabilities
Liabilities
873491000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60160459
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48841343
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59390194
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48068881
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
476072000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
486056000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
452445000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
409268000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8769000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8478000
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
247398000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
247431000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
672356000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
639421000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1574317000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1512912000
CY2024Q1 us-gaap Revenues
Revenues
171836000
CY2023Q1 us-gaap Revenues
Revenues
140022000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
81736000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
66182000
CY2024Q1 us-gaap Gross Profit
GrossProfit
90100000
CY2023Q1 us-gaap Gross Profit
GrossProfit
73840000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9371000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7109000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15676000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13483000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17043000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19815000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
42090000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
40407000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
48010000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
33433000
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2556000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
924000
CY2024Q1 us-gaap Interest Expense
InterestExpense
8611000
CY2023Q1 us-gaap Interest Expense
InterestExpense
398000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5921000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-390000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-134000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
136000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47876000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33569000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4126000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6752000
CY2024Q1 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
43750000
CY2023Q1 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
26817000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-573000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-785000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43177000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26032000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48212000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48000000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53013000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51970000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43177000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26032000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-291000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
356000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-291000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
356000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
42886000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26388000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
639421000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43177000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-291000
CY2024Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
-17311000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7360000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
672356000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
528658000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26032000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
356000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8015000
CY2023Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
-4565000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6111000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
548577000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
43177000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
26032000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-2000
CY2024Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
4645000
CY2023Q1 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-195000
CY2024Q1 us-gaap Depreciation
Depreciation
6816000
CY2023Q1 us-gaap Depreciation
Depreciation
6252000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6167000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
241000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
980000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
903000
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2128000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
59000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-573000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-785000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7360000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6111000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23201000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11796000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9995000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-268000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
192000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-219000
CY2024Q1 amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
-3992000
CY2023Q1 amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
-6459000
CY2024Q1 amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-947000
CY2023Q1 amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-862000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
23078000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5514000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
55291000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40382000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8793000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9477000
CY2024Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
22507000
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
10574000
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
47497000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
14064000
CY2024Q1 amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
960000
CY2023Q1 amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
346000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15237000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6333000
CY2024Q1 amph Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options Net Of Withholding Tax Payments
ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsNetOfWithholdingTaxPayments
17311000
CY2023Q1 amph Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options Net Of Withholding Tax Payments
ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsNetOfWithholdingTaxPayments
4565000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8015000
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
252000
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4082000
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
98000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
968000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13579000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13548000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-97000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
56852000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20517000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
144531000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156333000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201383000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176850000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5943000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4802000
CY2023Q1 amph Noncash Operating Lease Right Of Use Asset
NoncashOperatingLeaseRightOfUseAsset
1150000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
8632000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1245000
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
349000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
336000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:14pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The principal accounting estimates include: fair value of acquired assets, determination of allowances for credit losses, fair value of financial instruments, allowance for discounts, provision for chargebacks and rebates, provision for product returns, adjustment of inventory to its net realizable value, impairment of investments, long-lived and intangible assets and goodwill, accrual for workers’ compensation liabilities, litigation reserves, stock price volatility for share-based compensation expense, valuation allowances for deferred tax assets, and liabilities for uncertain income tax positions.</p>
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-700000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
600000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2024Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2200000
CY2023Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2200000
CY2023Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
27920000
CY2022Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
26606000
CY2024Q1 amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
61971000
CY2023Q1 amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
69027000
CY2024Q1 amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
55673000
CY2023Q1 amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
67289000
CY2024Q1 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
34218000
CY2023Q1 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
28344000
CY2024Q1 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
34218000
CY2023Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
27920000
CY2024Q1 us-gaap Revenues
Revenues
171836000
CY2023Q1 us-gaap Revenues
Revenues
140022000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9662000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3399000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43177000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26032000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48212000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48000000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4801000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3970000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53013000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51970000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q1 us-gaap Revenues
Revenues
171836000
CY2023Q1 us-gaap Revenues
Revenues
140022000
CY2024Q1 us-gaap Gross Profit
GrossProfit
90100000
CY2023Q1 us-gaap Gross Profit
GrossProfit
73840000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
42090000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
40407000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
48010000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
33433000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-134000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
136000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47876000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33569000
CY2024Q1 us-gaap Revenues
Revenues
171836000
CY2023Q1 us-gaap Revenues
Revenues
140022000
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
893250000
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
894662000
CY2024Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
84661000
CY2024Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
9000
CY2024Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
125000
CY2024Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
84545000
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
89517000
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
64000
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
22000
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
89559000
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P24Y
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
594364000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19677000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
574687000
CY2024Q1 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32377000
CY2024Q1 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32377000
CY2024Q1 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
626741000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19677000
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
607064000
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P11Y
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
602826000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21972000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
580854000
CY2023Q4 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32441000
CY2023Q4 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32441000
CY2023Q4 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
635267000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21972000
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
613295000
CY2023Q4 us-gaap Goodwill
Goodwill
3216000
CY2022Q4 us-gaap Goodwill
Goodwill
3126000
CY2024Q1 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-64000
CY2023 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
90000
CY2024Q1 us-gaap Goodwill
Goodwill
3152000
CY2023Q4 us-gaap Goodwill
Goodwill
3216000
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
51411000
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
50082000
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
33331000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
30822000
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
30752000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
24929000
CY2024Q1 us-gaap Inventory Net
InventoryNet
115494000
CY2023Q4 us-gaap Inventory Net
InventoryNet
105833000
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
5700000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
1900000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
540131000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
528044000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
251608000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
245298000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
288523000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282746000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33569000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4126000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6752000
CY2024Q1 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
43750000
CY2023Q1 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
26817000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.086
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.201
CY2024Q1 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
29002000
CY2023Q4 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
16702000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25392000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25203000
CY2024Q1 amph Product Return Accrual Current
ProductReturnAccrualCurrent
12704000
CY2023Q4 amph Product Return Accrual Current
ProductReturnAccrualCurrent
12263000
CY2024Q1 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
3632000
CY2023Q4 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
918000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9433000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12842000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
80163000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
67928000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
36534000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25438000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
116697000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
93366000
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
562000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
616000
CY2024Q1 us-gaap Contractual Obligation
ContractualObligation
607773000
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
603790000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
428000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
436000
CY2024Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
13339000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
13775000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
594006000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
589579000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47876000
CY2024Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
285000000.0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.413
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.415
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7762298
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.70
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
579532
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
46.68
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1160737
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.70
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3830
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
35.97
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7177263
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.01
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
151732000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5336486
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
18.53
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
135419000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6970643
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
22.55
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M21D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
150339000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
22.16
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.67
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
35823000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2341000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1821000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1388000
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8663000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7584000
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2076355
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
12.68
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
579532
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
22.16
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
811280
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
10.68
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
3830
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
16.63
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1840777
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
16.54
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7360000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6111000
CY2024Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2024Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2024Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
800000
CY2023Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
600000
CY2024Q1 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.0325
CY2024Q1 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2600000
CY2023Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2600000
CY2024Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
7800000
CY2023Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
6800000
CY2024Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
8100000
CY2023Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
7100000

Files In Submission

Name View Source Status
0001297184-24-000037-index-headers.html Edgar Link pending
0001297184-24-000037-index.html Edgar Link pending
0001297184-24-000037.txt Edgar Link pending
0001297184-24-000037-xbrl.zip Edgar Link pending
amph-20240331.xsd Edgar Link pending
amph-20240331x10q.htm Edgar Link pending
amph-20240331xex10d1.htm Edgar Link pending
amph-20240331xex10d1001.jpg Edgar Link pending
amph-20240331xex10d1002.jpg Edgar Link pending
amph-20240331xex10d1004.jpg Edgar Link pending
amph-20240331xex10d1006.jpg Edgar Link pending
amph-20240331xex10d1008.jpg Edgar Link pending
amph-20240331xex10d1011.jpg Edgar Link pending
amph-20240331xex31d1.htm Edgar Link pending
amph-20240331xex31d2.htm Edgar Link pending
amph-20240331xex32d1.htm Edgar Link pending
amph-20240331xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
amph-20240331_cal.xml Edgar Link unprocessable
amph-20240331_def.xml Edgar Link unprocessable
amph-20240331_lab.xml Edgar Link unprocessable
amph-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
amph-20240331x10q_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending